Gottfried E. Konecny, MD

Gottfried Konecny, MD

Professor, Department of Medicine, Hematology/Oncology

Languages

English, German

Specialty

Gynecologic Oncology, Breast Medical Oncology

Institutional Affiliation

UCLA Medical Center, Santa Monica

Education

Fellowship

Gynecologic Oncology, Mayo Clinic, 2005 - 2007

Internship

Obstetrics and Gynecology, Klinikum Grosshadern (University of Munich), 1989 - 1991

Degrees

Habilitation, Ludwig-Maximilians Universitat Muenchen, 2002
MD, Ludwig-Maximilians Universitat Muenchen, 1991

Residency

Obstetrics and Gynecology, Klinikum Grosshadern (University of Munich), 1991 - 1996

Board Certification

Obstetrics and Gynecology (Germany), 1996

Contact Information

Clinical Interests

Breast Cancer, Cervical Cancer, Endometrial Cancer, Ovarian Cancer

Scientific Interests

Dr. Gottfried Konecny is interested in the development of novel targeted therapies for ovarian, endometrial, cervical and breast cancers.

Highlighted Publications

Untch M, Mobus V, Kuhn W, Muck BR, Thomssen C, Bauerfeind I, Harbeck N, Werner C, Lebeau A, Schneeweiss A, Kahlert S, von Koch F, Petry KU, Wallwiener D, Kreienberg R, Albert US, Luck HJ, Hinke A, Janicke F, Konecny GE. Intensive dose-dense compared with conventionally scheduled preoperative chemotherapy for high-risk primary breast cancer. J Clin Oncol. 2009 Jun 20;27(18):2938-45. Epub 2009 Apr 13.

Konecny GE, Santos L, Winterhoff B, Hatmal M, Keeney GL, Mariani A, Jones M, Neuper C, Thomas B, Muderspach L, Riehle D, Wang HJ, Dowdy S, Podratz KC, Press MF. HER2 gene amplification and EGFR expression in a large cohort of surgically staged patients with nonendometrioid (type II) endometrial cancer. Br J Cancer. 2009 Jan 13;100(1):89-95. Epub 2008 Dec 16.

Konecny GE, Pegram MD, Venkatesan N, Finn R, Yang G, Rahmeh M, Untch M, Rusnak DW, Spehar G, Mullin RJ, Keith BR, Gilmer TM, Berger M, Podratz KC, Slamon DJ. Activity of the dual kinase inhibitor lapatinib (GW572016) against HER-2-overexpressing and trastuzumab-treated breast cancer cells. Cancer Res. 2006 Feb 1;66(3):1630-9.

Konecny GE, Thomssen C, Luck HJ, Untch M, Wang HJ, Kuhn W, Eidtmann H, du Bois A, Olbricht S, Steinfeld D, Mobus V, von Minckwitz G, Dandekar S, Ramos L, Pauletti G, Pegram MD, Janicke F, Slamon DJ. Her-2/neu gene amplification and response to paclitaxel in patients with metastatic breast cancer. J Natl Cancer Inst. 2004 Aug 4;96(15):1141-51.

Konecny G, Pauletti G, Pegram M, Untch M, Dandekar S, Aguilar Z, Wilson C, Rong HM, Bauerfeind I, Felber M, Wang HJ, Beryt M, Seshadri R, Hepp H, Slamon DJ. Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer. J Natl Cancer Inst. 2003 Jan 15;95(2):142-53.